JW Pharmaceutical Corporation (KRX:001060)
23,050
+50 (0.22%)
At close: Jun 5, 2025, 3:30 PM KST
JW Pharmaceutical Revenue
JW Pharmaceutical had revenue of 185.24B KRW in the quarter ending March 31, 2025, with 2.57% growth. This brings the company's revenue in the last twelve months to 724.02B, down -4.20% year-over-year. In the year 2024, JW Pharmaceutical had annual revenue of 719.38B, down -3.89%.
Revenue (ttm)
724.02B
Revenue Growth
-4.20%
P/S Ratio
0.74
Revenue / Employee
677.92M
Employees
1,068
Market Cap
534.46B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 719.38B | -29.15B | -3.89% |
Dec 31, 2023 | 748.53B | 64.18B | 9.38% |
Dec 31, 2022 | 684.35B | 77.77B | 12.82% |
Dec 31, 2021 | 606.58B | 59.25B | 10.83% |
Dec 31, 2020 | 547.34B | 36.00B | 7.04% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Samsung Biologics | 4,898.69B |
Celltrion | 3,662.23B |
ALTEOGEN | 151.65B |
Yuhan | 2,114.76B |
SK Biopharmaceuticals | 578.00B |
HLB Co., Ltd. | 74.64B |
PharmaResearch | 392.31B |
LigaChem Biosciences | 146.42B |